Cancer Research Cell Death Mechanisms and Cancer Therapy EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hefler, L. A.
Right arrow Articles by Tempfer, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hefler, L. A.
Right arrow Articles by Tempfer, C. B.
[Cancer Research 63, 3066-3068, June 15, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer

Lukas A. Hefler1, Christoph Grimm, Sven Ackermann, Sabine Malur, Amir R. Radjabi-Rahat, Sepp Leodolter, Matthias W. Beckmann, Robert Zeillinger, Heinz Koelbl and Clemens B. Tempfer

Departments of Obstetrics and Gynecology, University of Vienna Medical School, A-1090 Vienna, Austria [L. A. H., C. G., A. R. R-R., S. L., R. Z., C. B. T.]; Friedrich-Alexander-University Erlangen, Nuernberg, Germany [L. A. H., S. A., S. M., M. W. B.]; and Martin-Luther-University Halle, Wittenberg, Germany [H. K.]

Interleukin (IL)-6 is known to be involved in the pathogenesis of ovarian cancer. We investigated a common G/C polymorphism at position -174 of the IL-6 gene (IL6) promoter in 121 patients with ovarian cancer using pyrosequencing. Presence of at least one mutant allele was associated with early tumor stage as well as an expanded length of disease-free (DFS) and overall survival with a dose-dependent effect regarding the carriage of 0, 1, and 2 alleles. In a multivariate Cox regression model incorporating tumor stage and residual tumor mass, presence of the -174 C allele of IL6 was the best predictor of DFS. We conclude that the mutant -174 C allele of IL6 influences the biological phenotype of ovarian cancer because it is associated with early stage and improved DFS and overall survival.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
S. Wilkening, B. Tavelin, F. Canzian, K. Enquist, R. Palmqvist, A. Altieri, G. Hallmans, K. Hemminki, P. Lenner, and A. Forsti
Interleukin promoter polymorphisms and prognosis in colorectal cancer
Carcinogenesis, June 1, 2008; 29(6): 1202 - 1206.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Song, E. Hogdall, S. J. Ramus, R. A. DiCioccio, C. Hogdall, L. Quaye, V. McGuire, A. S. Whittemore, M. Shah, D. Greenberg, et al.
Effects of Common Germ-Line Genetic Variation in Cell Cycle Genes on Ovarian Cancer Survival
Clin. Cancer Res., February 15, 2008; 14(4): 1090 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. A. Hefler, A. Mustea, D. Konsgen, N. Concin, B. Tanner, R. Strick, G. Heinze, C. Grimm, E. Schuster, C. Tempfer, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 898 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Wrensch, A. McMillan, J. Wiencke, J. Wiemels, K. Kelsey, J. Patoka, H. Jones, V. Carlton, R. Miike, J. Sison, et al.
Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis
Clin. Cancer Res., January 1, 2007; 13(1): 197 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, R. Zeillinger, G. Sliutz, A. Reinthaller, and L. A. Hefler
A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer
Reproductive Sciences, December 1, 2005; 12(8): 617 - 620.
[Abstract] [PDF]

Home page
 JCOHome page
D. Leibovici, H. B. Grossman, C. P. Dinney, R. E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dong, and X. Wu
Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival
J. Clin. Oncol., August 20, 2005; 23(24): 5746 - 5756.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. Bhanoori, K. A. Babu, M. Deenadayal, S. Kennedy, and S. Shivaji
The Interleukin-6 -174G/C Promoter Polymorphism Is Not Associated With Endometriosis in South Indian Women
Reproductive Sciences, July 1, 2005; 12(5): 365 - 369.
[Abstract] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
M.J. BISSELL, P.A. KENNY, and D.C. RADISKY
Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression: The Role of Extracellular Matrix and Its Degrading Enzymes
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 343 - 356.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
A. Huber, C. Grimm, S. Jirecek, R. Zeillinger, K. Heim, P. Husslein, and L. Hefler
An lnterleukin-6 Gene Promoter Polymorphism and Unexplained Late Intrauterine Fetal Death: A Multicenter Study
Reproductive Sciences, January 1, 2005; 12(1): 33 - 36.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.